子宫癌肉瘤/恶性混合性苗勒管肿瘤的发病率在乳腺癌女性中有所增加，但与激素治疗无关。 - Suppr

Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy.

作者信息

Wilson Brian T, Cordell Heather J

机构信息

Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.

Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, International Centre for Life, Newcastle upon Tyne, UK.

出版信息

J Gynecol Oncol. 2015 Oct;26(4):249-51. doi: 10.3802/jgo.2015.26.4.249. Epub 2015 Sep 23.

DOI:10.3802/jgo.2015.26.4.249

PMID:26404129

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4620359/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbfe/4620359/be9c25709759/jgo-26-249-g001.jpg

相似文献

Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy.子宫癌肉瘤/恶性混合性苗勒管肿瘤的发病率在乳腺癌女性中有所增加，但与激素治疗无关。

J Gynecol Oncol. 2015 Oct;26(4):249-51. doi: 10.3802/jgo.2015.26.4.249. Epub 2015 Sep 23.

Breast Cancer is Common in Women With Ovarian Malignant Mixed Mullerian Tumors.乳腺癌在患有卵巢恶性混合性苗勒管肿瘤的女性中很常见。

Am J Clin Oncol. 2018 Mar;41(3):286-288. doi: 10.1097/COC.0000000000000266.

Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study.在苏格兰东北部，子宫癌肉瘤的发病率是否增加？一项基于人群的 19 年队列研究。

Scott Med J. 2013 May;58(2):88-94. doi: 10.1177/0036933013482637.

Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry.BRCA1和BRCA2基因突变携带者中的第二原发性乳腺癌：乳腺癌家族登记处的10年累积发病率。

Breast Cancer Res Treat. 2015 Jun;151(3):653-60. doi: 10.1007/s10549-015-3419-y. Epub 2015 May 15.

[Carcinosarcomas in female genital tracts: general review].[女性生殖道癌肉瘤：综述]

Bull Cancer. 2014 Jul-Aug;101(7-8):760-4. doi: 10.1684/bdc.2014.1937.

CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).源自子宫癌肉瘤（恶性混合 Müllerian 肿瘤）的 CD133+ 癌症干细胞样细胞。

Stem Cells. 2011 Oct;29(10):1485-95. doi: 10.1002/stem.711.

Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers.

Eur J Cancer. 2006 Mar;42(5):650-5. doi: 10.1016/j.ejca.2005.08.045. Epub 2006 Feb 7.

p53 immunostaining suggests that uterine carcinosarcomas are monoclonal.

Histopathology. 1994 Mar;24(3):211-4. doi: 10.1111/j.1365-2559.1994.tb00512.x.

HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy.

Pathol Res Pract. 2005;201(2):141-4. doi: 10.1016/j.prp.2004.11.009.

Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.8例子宫恶性苗勒管混合瘤（癌肉瘤）：SurePath™宫颈细胞学检查结果

Diagn Cytopathol. 2014 Feb;42(2):165-9. doi: 10.1002/dc.22910. Epub 2012 Aug 4.

引用本文的文献

Carcinosarcoma of the Endometrium-Pathology, Molecular Landscape and Novel Therapeutic Approaches.子宫内膜癌肉瘤——病理学、分子格局与新型治疗方法

Medicina (Kaunas). 2025 Jun 26;61(7):1156. doi: 10.3390/medicina61071156.

Uterine carcinosarcomas: A case series of 9 cases from a low-income country.子宫癌肉瘤：来自一个低收入国家的 9 例病例系列。

Medicine (Baltimore). 2024 Oct 4;103(40):e39773. doi: 10.1097/MD.0000000000039773.

Mutational landscape implicates epithelial-mesenchymal transition gene TGF-β2 mutations for uterine carcinosarcoma after adjuvant tamoxifen therapy for breast carcinoma.突变图谱显示，在乳腺癌辅助他莫昔芬治疗后，子宫癌肉瘤存在上皮-间质转化基因TGF-β2突变。

Int J Clin Exp Pathol. 2019 Mar 1;12(3):996-1002. eCollection 2019.

Uterine Malignant Mixed Müllerian Tumors Following Treatment with Selective Estrogen Receptor Modulators in Patients with Breast Cancer: A Report of 13 Cases and Their Clinicopathologic Characteristics.乳腺癌患者接受选择性雌激素受体调节剂治疗后发生的子宫恶性混合性苗勒管肿瘤：13例报告及其临床病理特征

J Pathol Transl Med. 2019 Jan;53(1):31-39. doi: 10.4132/jptm.2018.11.16. Epub 2018 Dec 18.

本文引用的文献

Immunohistochemical loss of BRCA1 protein in uterine serous carcinoma.

Int J Gynecol Pathol. 2014 May;33(3):282-7. doi: 10.1097/PGP.0b013e318290409c.

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.BRCA1/2 相关乳腺癌患者行对侧乳房切除术可改善生存。

Breast Cancer Res Treat. 2013 Jul;140(1):135-42. doi: 10.1007/s10549-013-2583-1. Epub 2013 Jun 20.

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.BRCA1 和 BRCA2 基因突变女性的子宫内膜癌发病率：一项国际前瞻性队列研究。

Gynecol Oncol. 2013 Jul;130(1):127-31. doi: 10.1016/j.ygyno.2013.03.027. Epub 2013 Apr 3.

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.BRCA1、TP53 和 CHEK2 种系突变与子宫浆液性癌相关。

Cancer. 2013 Jan 15;119(2):332-8. doi: 10.1002/cncr.27720. Epub 2012 Jul 18.

Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.聚（ADP-核糖）聚合酶抑制剂 AG014699 在突变或甲基化 BRCA1 或 BRCA2 的人类癌症中的治疗潜力。

J Natl Cancer Inst. 2011 Feb 16;103(4):334-46. doi: 10.1093/jnci/djq509. Epub 2010 Dec 23.

Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.子宫癌肉瘤（恶性混合性苗勒管肿瘤）：生物学和临床特征阐释的进展

J Natl Compr Canc Netw. 2009 May;7(5):550-6; quiz 557. doi: 10.6004/jnccn.2009.0037.

Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.原发性乳腺癌患者随后被诊断为子宫内膜癌的结局：接受他莫昔芬治疗与未接受他莫昔芬治疗队列的比较。

Cancer. 2007 Jul 1;110(1):31-7. doi: 10.1002/cncr.22734.

Uterine sarcomas in breast cancer patients treated with tamoxifen.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):861-5. doi: 10.1111/j.1525-1438.2006.00415.x.

Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.他莫昔芬治疗乳腺癌后发生子宫肉瘤：4例报告。

Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1239-42. doi: 10.1111/j.1525-1438.2005.00170.x.

Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer.他莫昔芬与高危子宫内膜癌有关联吗？一项对196例子宫内膜癌女性患者的回顾性病例系列研究。

J Obstet Gynaecol. 2005 Jan;25(1):39-41. doi: 10.1080/01443610400024740.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献